Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

被引：0
作者：
H. H. J. Gerets
K. Tilmant
B. Gerin
H. Chanteux
B. O. Depelchin
S. Dhalluin
F. A. Atienzar
机构：
[1] UCB Pharma,
[2] Brussels,undefined
[3] Belgium,undefined
[4] Non-clinical Development,undefined
[5] Investigative Non-clinical Safety,undefined
[6] Chemin du Foriest,undefined
[7] UCB Pharma,undefined
[8] Brussels,undefined
[9] Belgium,undefined
[10] Non-clinical Development,undefined
[11] Non-clinical Drug Metabolism and Pharmacokinetics,undefined
[12] Chemin du Foriest,undefined
来源：
Cell Biology and Toxicology | 2012年 / 28卷
关键词：
CYP450 activities; Cytotoxicity; Gene expression; HepaRG cells; HepG2 cells; Primary human hepatocytes; Real-time cell analyzer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the pharmaceutical industry, improving the early detection of drug-induced hepatotoxicity is essential as it is one of the most important reasons for attrition of candidate drugs during the later stages of drug development. The first objective of this study was to better characterize different cellular models (i.e., HepG2, HepaRG cells, and fresh primary human hepatocytes) at the gene expression level and analyze their metabolic cytochrome P450 capabilities. The cellular models were exposed to three different CYP450 inducers; beta-naphthoflavone (BNF), phenobarbital (PB), and rifampicin (RIF). HepG2 cells responded very weakly to the different inducers at the gene expression level, and this translated generally into low CYP450 activities in the induced cells compared with the control cells. On the contrary, HepaRG cells and the three human donors were inducible after exposure to BNF, PB, and RIF according to gene expression responses and CYP450 activities. Consequently, HepaRG cells could be used in screening as a substitute and/or in complement to primary hepatocytes for CYP induction studies. The second objective was to investigate the predictivity of the different cellular models to detect hepatotoxins (16 hepatotoxic and 5 nonhepatotoxic compounds). Specificity was 100% with the different cellular models tested. Cryopreserved human hepatocytes gave the highest sensitivity, ranging from 31% to 44% (depending on the donor), followed by lower sensitivity (13%) for HepaRG and HepG2 cells (6.3%). Overall, none of the models under study gave desirable sensitivities (80–100%). Consequently, a high metabolic capacity and CYP inducibility in cell lines does not necessarily correlate with a high sensitivity for the detection of hepatotoxic drugs. Further investigations are necessary to compare different cellular models and determine those that are best suited for the detection of hepatotoxic compounds.
引用
收藏
页码：69 / 87
页数：18
相关论文
共 308 条
[1]  
Abassi Y(2009)Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects Chem Biol 16 1-12
[2]  
Xi B(2003)Evaluation of cytochrome P450-mediated hepatotoxicity using a high throughput robotic system Drug Metab Rev 35 413-83
[3]  
Zhang W(2006)Stable expression, activity and inducibility of cytochromes P450 in differentiated HepaRG cells Drug Metab Dispose 34 75-525
[4]  
Ye P(2010)The use of real-time cell analyzer technology in drug discovery: defining optimal cell culture conditions and assay reproducibility with different adherent cellular models Drug Met Disp. 38 516-587
[5]  
Kirstein S(2011)Controlling the false discovery rate: a practical and powerful approach to multiple testing J Biomol Screen 16 575-300
[6]  
Gaylord M(1995)New technologies and screening strategies for hepatoxicity: use of in vitro models J Roy Stat Soc Ser B 57 289-26
[7]  
Feinstein S(2005)Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes Toxicol Pathol 33 17-706
[8]  
Wang X(2004)Cell lines: a tool for in vitro drug metabolism studies Drug Metab Dispos 32 699-11
[9]  
Xu X(2008)Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential Curr Drug Metab 9 1-584
[10]  
Andrews B(2001)Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity Tox In Vitro 15 579-1230
12345678910